Instead, the addition of IFN-β to the BMM cultures at least partially reversed the bacterial control conferred by the USP18 inhibition.<h4>Discussion</h4>Our results suggest that the pharmacological inhibition of USP18 can be further explored as a therapeutic tool in the control of tuberculosis. The gene discussed is USP18; the disease is tuberculosis.